Clinical trial
An Open-Label, Pharmacokinetic and Safety Study of Travoprost Ophthalmic Solution, 0.004% in Pediatric Glaucoma or Ocular Hypertension Patients
NCT01658839 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label, Pharmacokinetic and Safety Study of Travoprost Ophthalmic Solution, 0.004% in Pediatric Glaucoma or Ocular Hypertension Patients
- Lead sponsor
- Alcon Research
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 31, 2013
- Completion date
- July 31, 2013
- Enrollment
- 25 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.